Live Breaking News & Updates on கொள்ளை பரோ

Stay updated with breaking news from கொள்ளை பரோ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial


MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial
News provided by
Share this article
MindMed Finalizes Clinical Development Approach for LSD Targeting Generalized Anxiety Disorder as Initial Indication
NEW YORK, May 17, 2021 /PRNewswire/  MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a leading clinical stage psychedelic medicine company, announces receipt of Type C Meeting Responses from FDA leading to the finalization of the Company s clinical development approach for Project Lucy by selecting Generalized Anxiety Disorder as an initial indication. MindMed is on target to formally submit its Investigational New Drug (IND) application for Project Lucy in Q3 2021 and expects to launch its Phase 2b clinical trial shortly thereafter in Q4 2021. ....

United States , Dan Karlin , Rob Barrow , Exchange Commission , National Institute Of Mental Health , Mindmed Finalizes Clinical Development , Medicine Mindmed Inc , Mindmed Finalizes Clinical Development Approach , Generalized Anxiety Disorder , Typec Meeting Responses , Project Lucy , Investigational New Drug , Generalized Anxiety , Chief Development Officer , Anxiety Disorder , National Institute , Mental Health , Major Depressive Disorder , Med Chief Medical Officer , Major Depressive Disorders , Mindmed Chief Medical Officer , Mind Medicine Mindmed Inc , ஒன்றுபட்டது மாநிலங்களில் , டான் கார்லின் , கொள்ளை பரோ , பரிமாற்றம் தரகு ,